Loading…
Celcuity Inc. is projected to rise to $178.23 by 2027, a +33% move from its current price of $133.97. CELC is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $129.40 | $134.03 | $138.84 | +0.05% |
| May 30 | $127.59 | $134.10 | $140.94 | +0.09% |
| May 31 | $126.23 | $134.16 | $142.59 | +0.14% |
| Jun 1 | $125.10 | $134.22 | $144.01 | +0.19% |
| Jun 2 | $124.12 | $134.29 | $145.28 | +0.24% |
| Jun 3 | $123.25 | $134.35 | $146.45 | +0.28% |
| Jun 4 | $122.46 | $134.41 | $147.53 | +0.33% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $122.46 | $134.41 | $147.53 | +0.33% |
| Week 2 | $118.22 | $134.86 | $153.84 | +0.67% |
| Week 3 | $115.15 | $135.31 | $158.99 | +1.00% |
| Week 4 | $112.69 | $135.76 | $163.55 | +1.33% |
| Week 5 | $110.60 | $136.21 | $167.74 | +1.67% |
| Week 6 | $108.79 | $136.66 | $171.68 | +2.01% |
| Week 7 | $107.17 | $137.11 | $175.42 | +2.35% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Celcuity Inc. is a clinical-stage biotechnology company focused on developing targeted therapies for solid tumors in the United States. Its lead drug candidate Gedatolisib selectively targets PI3K isoforms and mTOR sub-complexes to treat HR+, HER2- or HR+/HER2-, advanced or metastatic breast cancer, and patients with metastatic castration resistant prostate cancer.
The company had a license agreement with Pfizer Inc. for Gedatolisib.
Celcuity was incorporated in 2011 and is based in Minneapolis, Minnesota.
Celcuity Inc. trades with a current price of $138.23 and a market capitalization of $6.74B. Its rank is 1137.
The near-term forecast for 2026 shows min $100.55, avg $138.23, max $206.95 with ROI 0 and sentiment NEUTRAL. This suggests a flat outlook around the current price in the coming year.
From 2027 onward, the forecast turns bullish with rising averages and ROI. The 2027 avg is $182.62 (ROI 32.1%), 2028 avg $208.34 (50.7%), and 2029 avg $237.69 (72%). The 2030 avg climbs to $321.97 (132.9%), followed by continued gains through 2031 $426.98 (208.9%), 2032 $461.12 (233.6%), 2033 $500.80 (262.3%), 2034 $528.61 (282.4%), and 2035 $575.32 (316.2%).
Longer-horizon targets include 2040 avg $1,002.82 (625.5%) and 2050 avg $2,758.61 (1,895.7%), all with bullish sentiment.
A major floor 25.8% below — a decisive break under it would weaken the trend.
The nearest floor, 15.2% below — buyers have tended to step in here.
The nearest ceiling, 8.2% above — a clean break opens room to run.
A major ceiling 21.1% above — clearing it would confirm fresh momentum.
Key CELC support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of CELC market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $137.87 | Sell | $135.65 | Sell |
| MA 10 | $134.93 | Sell | $134.83 | Sell |
| MA 20 | $132.68 | Buy | $132.11 | Buy |
| MA 50 | $122.74 | Buy | $124.90 | Buy |
| MA 100 | $115.80 | Buy | $114.67 | Buy |
| MA 200 | $93.72 | Buy | $94.90 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 53.52 | Neutral |
| Stoch RSI (14) | 30.42 | Neutral |
| CCI (20) | 14.11 | Neutral |
| Williams %R (14) | -47.40 | Info |
| MACD (12,26,9) | -0.19 | Sell |
| ROC (12) | 2.22 | Buy |
| Bollinger %B (20,2) | 0.54 | Neutral |
| Stochastic %K (14) | 52.60 | Neutral |
| TRIX (15) | 0.47 | Buy |
| Awesome (5,34) | 9.73 | Buy |
| Ultimate (7,14,28) | 45.13 | Neutral |
| Momentum (10) | 9.29 | Buy |
| Aroon Osc (25) | 28.00 | Buy |
| Hull MA (9) | 137.55 | Sell |
| ADX (14) | 12.94 | Neutral |
| ATR (14) | 4.11 | Info |
The 30-day technical picture shows a bullish tilt with a 30-day range of $108.42 to $176.23. RSI14 is 60, SMA50 is $121.95, and SMA200 is $92.83.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $100.55 | $133.97 | $197.62 | 0% | Neutral | |
| $137.40 | $178.23 | $247.14 | +33% | Bullish | |
| $153.28 | $206.16 | $298.75 | +54% | Bullish | |
| $167.12 | $231.74 | $347.65 | +73% | Bullish | |
| $220.54 | $314.27 | $485.41 | +135% | Bullish | |
| $286.53 | $418.68 | $663.33 | +213% | Bullish | |
| $301.91 | $451.68 | $732.06 | +237% | Bullish | |
| $325.59 | $498.09 | $824.04 | +272% | Bullish | |
| $336.91 | $526.50 | $887.65 | +293% | Bullish | |
| $355.62 | $567.27 | $973.24 | +323% | Bullish | |
| $576.17 | $1,010.55 | $1,864.84 | +654% | Bullish | |
| $1,311.54 | $2,727.95 | $5,591.33 | +19.4x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $100.55 | $133.97 | $158.96 | +0.00% |
| June 2026 | $119.35 | $141.05 | $171.30 | +5.28% |
| July 2026 | $117.08 | $139.88 | $172.83 | -0.83% |
| August 2026 | $115.60 | $139.31 | $174.39 | -0.41% |
| September 2026 | $119.63 | $145.19 | $183.71 | +4.23% |
| October 2026 | $121.36 | $148.26 | $189.40 | +2.11% |
| November 2026 | $119.51 | $146.84 | $189.17 | -0.96% |
| December 2026 | $123.18 | $152.19 | $197.62 | +3.65% |
Click any year to see its month-by-month CELC forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect CELC to range from $100.55 to $197.62 through 2026. The $133.97 average target implies a 0% move from current prices. Price action looks broadly range-bound.
The CELC price prediction for 2027 points to an average of $178.23 (low $137.40, high $247.14) — a potential gain of +33% on today's $133.97. Buyers look set to stay in control over this stretch.
In 2028, CELC is projected to trade between $153.28 and $298.75, averaging $206.16 — a potential gain of +54% from today's $133.97. That is up +16% on the projected 2027 average. Momentum favours further upside here.
Celcuity Inc.'s 2029 outlook centres on $231.74, within a $167.12 to $347.65 range. That is up +12% on the projected 2028 average. That marks a +73% change versus current levels. Buyers look set to stay in control over this stretch.
By 2030, CELC could reach as high as $485.41, with a base case around $314.27 and support toward $220.54 — roughly +135% from $133.97. Momentum favours further upside here.
Expect CELC to range from $286.53 to $663.33 through 2031. The $418.68 average target implies a +213% move from current prices. That is up +33% on the projected 2030 average. Buyers look set to stay in control over this stretch.
The CELC price prediction for 2032 points to an average of $451.68 (low $301.91, high $732.06) — a potential gain of +237% on today's $133.97. Momentum favours further upside here.
In 2033, CELC is projected to trade between $325.59 and $824.04, averaging $498.09 — a potential gain of +272% from today's $133.97. That is up +10% on the projected 2032 average. Buyers look set to stay in control over this stretch.
Celcuity Inc.'s 2034 outlook centres on $526.50, within a $336.91 to $887.65 range. That is up +6% on the projected 2033 average. That marks a +293% change versus current levels. Momentum favours further upside here.
By 2035, CELC could reach as high as $973.24, with a base case around $567.27 and support toward $355.62 — roughly +323% from $133.97. Buyers look set to stay in control over this stretch.
Expect CELC to range from $576.17 to $1,864.84 through 2040. The $1,010.55 average target implies a +654% move from current prices. That is up +78% on the projected 2035 average. Momentum favours further upside here.
The CELC price prediction for 2050 points to an average of $2,727.95 (low $1,311.54, high $5,591.33) — a potential gain of +19.4x on today's $133.97. Buyers look set to stay in control over this stretch.
Investing $1,000 in CELC today (≈ 7.464358 CELC) could be worth
$20,362.38
+$19,362.38 (+1936%) by 2050 · US Dollar
Based on the average projected CELC price of $2,727.95 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in CELCwould be worth at today's price.
$1,000 invested in CELC on May 27, 2025 (≈ 94.876661 CELC) would be worth
$12,710.63
+$11,710.63 (+1171.1%) today · 12.71× · US Dollar
Based on a CELC entry price of $10.54 vs. today's $133.97.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $140.34 | $954.61 | -4.5% |
| 1 month ago | $125.68 | $1,065.96 | +6.6% |
| 3 months ago | $111.12 | $1,205.63 | +20.6% |
| 6 months ago | $101.14 | $1,324.6 | +32.5% |
| 1 year ago | $10.54 | $12,710.63 | +1171.1% |
| All time (5.0y) ago | $27.05 | $4,952.68 | +395.3% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our CELC forecast.
Our base-case forecast reaches $270.00 around 2030.
Implied market cap at $270.00: $13.17B
The multi-year forecast points to substantial upside with bullish sentiment through 2050. The forecasted averages rise from 2027 onward, with 2027 avg $182.62 (ROI 32.1%), 2028 avg $208.34 (50.7%), 2029 avg $237.69 (72%), and 2030 avg $321.97 (132.9%). The momentum continues to 2040 with avg $1,002.82 (625.5%) and reaches 2050 with avg $2,758.61 (1,895.7%).
These figures illustrate a long-run expansion path, albeit these are estimates, not guarantees, and depend on future clinical and regulatory outcomes.
Tap a question to reveal the answer.
2030 avg $321.97; min $223.32; max $503.31; ROI 132.9%; sentiment BULLISH.
Forecasts show a neutral stance in 2026 and bullish sentiment from 2027 onward, with rising averages and sizable long-term upside (2030 avg $321.97; 2040 avg $1,002.82; 2050 avg $2,758.61). These are estimates, not guarantees.
Yes, the 2030 forecast lists a max of $503.31, with an average of $321.97 and a 132.9% ROI.
RSI14 is 60. SMA50 is $121.95. SMA200 is $92.83. The 30-day range is $108.42 to $176.23, with support at $113.56 and resistance at $144.98.
Key long-term targets include 2040 avg $1,002.82 (ROI 625.5%) and 2050 avg $2,758.61 (ROI 1,895.7%).
Celcuity Inc. Community Discussion
0Share your Celcuity Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.